Welcome to BrainQ's neurorecovery blog
NEWS UPDATE: First Patient Enrolled in BrainQ's Pivotal Trial, EMAGINE™, for Frequency-Tuned Electromagnetic Field Therapy to Reduce Disability Following Ischemic Stroke
First patient enrolled at MedStar National Rehabilitation Hospital in BrainQ's pivotal study
BrainQ team | 09/12/2021
NEWS UPDATE: Breakthrough Israeli stroke therapy technology BrainQ announces a $40M funding round
BrainQ announces a $40M funding round
BrainQ team | 16/8/2021
Empowering Innovation With Regulation: Interview with Giovanni Lauricella, “Mister MedTech”
Brain computer interface technologies and modern innovation
BrainQ team | 27/6/2021
The journey of stroke recovery in 2021
Stroke is one of the most devastating and most prominent causes of disability around the globe, with 800,000 new cases each year in the US alone.
BrainQ team | 25/4/2021
NEWS UPDATE: BrainQ announces encouraging study results for new therapy to reduce disability after stroke
The stroke disability study presented 77% of the treatment group recovered to a level of no symptoms or no significant disability on the modified Rankin Scale
BrainQ team | 11/3/2021
NEWS UPDATE: BrainQ gets FDA Breakthrough status for its device for reducing disability following stroke
The Breakthrough Device designation, which comes after new trial data, is expected to expedite the device's path to market. Read more about the news here
BrainQ team | 11/2/2021
SALT Talks: Pandemic venture investment series recap: Artificial intelligence—digital health’s secret weapon
SALT Talks: Pandemic venture investment series recap: Artificial intelligence—digital health’s secret weapon...one of the hottest topics in today’s healthcare landscape
BrainQ team | 14/12/2020
Unlocking the potential of collaborative neurotrauma research: Interview with BrainQ CSO and Co-founder, Prof. Esty Shohami
Unlocking the potential of neurotrauma research
BrainQ team | 10/12/2020
An open letter to the neuro-community: The need for a roundtable approach to manage neurodisorders during COVID-19
Covid-19 has accelerated the need for an integrative approach to treating neurodisorders
Yotam Drechsler | 16/9/2020
How COVID-19 transformed the landscape for growing MedTech startups: Interview with BrainQ CEO & Co-founder, Yotam Drechsler
Covid-19 has transformed the MedTech startup landscape
BrainQ team | 15/9/2020
The new normal stroke victims face during the COVID-19 pandemic
Challenges faced by stroke victims during Covid-19
BrainQ team | 14/9/2020